adpt: the income statement

MyFinsight

Adaptive Biotechnologies Corp (ADPT)

For the quarter ending 2025-06-30, ADPT made $58,879K in revenue. -$25,614K in net income. Net profit margin of -43.50%.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

	2025-06-30	2025-03-31	2024-09-30
Revenue	58,879	52,443	46,435
Sales and marketing	23,573	23,047	20,551
Research and development	24,134	24,203	24,163
General and administrative	17,786	17,399	17,258
Cost of revenue	17,999	16,979	16,667
Amortization of intangible assets	423	419	428
Total operating expenses	83,915	82,047	79,067
Loss from operations	-25,036	-29,604	-32,632
Interest expense	2,948	2,905	2,939
Interest and other income, net	2,391	2,679	3,474
Net loss	-25,593	-29,830	-32,097
Add net (income) loss attributable to noncontrolling interest	21	22	-26
Net loss attributable to adaptive biotechnologies corporation	-25,614	-29,852	-32,071

Earnings per share, basic	-0.17	-0.2	-0.22
Earnings per share, diluted, total	-0.17	-0.2	-0.22
Weighted average number of shares outstanding, basic, total	152,082,284	149,195,028	147,516,398
Weighted average number of shares outstanding, diluted, total	152,082,284	149,195,028	147,516,398

Unit: Thousand (K) dollars (except for numbers of shares and EPS)